Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sascan Meditech is an Indian medtech and healthcare innovation company developing biophotonics-based cancer screening and diagnostic devices. The company focuses on non-invasive, point-of-care detection of potentially malignant and cancerous lesions using multispectral imaging, tissue autofluorescence, diffuse reflectance, and software-driven image analysis. Its flagship product, OralScan, is marketed for early detection of oral cancer and biopsy guidance, and the company is also developing CerviScan for cervical cancer screening along with adjacent photodynamic-therapy related products. Sascan positions its technology as affordable, clinically validated, and suitable for large-scale screening, especially in resource-constrained settings. The company is building R&D and manufacturing capacity in Thiruvananthapuram, Kerala.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sascan Meditech.